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فحص مستوى الرتوبونني يف قسم الطوارئ
جتربة من الواقع
حممد امل�صكري، حممود املكدمي، حامت اللواتي، حفيظ الهادي، �صونيل نادر
abstract: Objectives: The aim of this study was to examine patterns of troponin testing in the emergency 
department of a large tertiary care hospital in Oman and to determine its effect on patient management, including 
length of hospital stay (LOS). Methods: This retrospective study analysed the medical records of all adult patients 
undergoing troponin testing in the emergency department of the Sultan Qaboos University Hospital, Muscat, 
Oman, during the month of July 2015. Patients who presented with an ST-elevation myocardial infarction were 
excluded. Results: A total of 4,845 patients attended the emergency department during the study period; of 
these, troponin tests were ordered for 588 patients. The majority of the patients had negative troponin test results 
(81.3%). Chest pain, palpitations and breathlessness were the most common presenting complaints for those with 
positive troponin results. However, 41.8% of patients did not have any cardiac symptoms. Individuals with positive 
troponin tests had a significantly longer LOS compared to those with negative tests (mean: three versus one day; 
P = 0.001). In total, only 28.2% of those with positive troponin test results had final diagnoses associated with 
a cardiac condition, such as heart failure, an acute coronary syndrome (ACS), atrial fibrillation or other types 
of arrhythmia. Conclusion: A positive troponin test was associated with increased LOS; however, only a small 
proportion of these patients had a final diagnosis associated with a cardiac condition. Guidelines should be provided 
to ensure that troponin testing is performed only in cases where an ACS is suspected.
Keywords: Emergency Department; Troponin; Cardiovascular Abnormality; Acute Coronary Syndrome; Length of 
Stay; Oman.
امللخ�ص: الهدف: تهدف هذه الدرا�صة لدرا�صة منط اإجراء فح�ض الرتوبونني يف ق�صم الطواري مب�صت�صفى كبري يف عمان يقدم الرعاية ال�صحية 
الثالثية وذلك لتحديد تاأثري هذه الفحو�صات على عالج املري�ض ومدة مكوثه بامل�صت�صفى. الطريقة: �صملت هذة الدرا�صة ال�صتعادية حتليل 
قابو�ض،  ال�صلطان  جامعة  مب�صت�صفى  الطوارئ  ق�صم  يف  الرتوبونني  مل�صتوى  فح�ض  على  ح�صلوا  الذين  البالغني  املر�صى  جميع  �صجالت 
 4,845 النتائج: ح�رش عدد  ST مرتفع.  ذات مقطع  قلبية  بنوبة  امل�صخ�صني  املر�صى  ا�صتثناء  2015. مت  يوليو  �صهر  م�صقط، عمان خالل 
ا. الغالبية العظمى من املر�صى جاءوا بنتيجة فح�ض  مري�صا اإىل ق�صم الطوارئ خالل فرتة الدرا�صة، ُعمل اختبار الرتوبونني لـ 588 مري�صً
�صلبية )%81.3(. اأمل ال�صدر، اخلفقان، و�صعوبة التنف�ض كانت اأكرث الأعرا�ض �صيوعًا بني املر�صى ذوي النتائج املوجبة للفح�ض، يف حني اأن 
%41.8 من املر�صى مل ي�صكوا من اأي اأعرا�ض قلبية. كما ظهر اأي�صًا اأن املر�صى ذوي النتائج املوجبة كانت فرتة بقائهم يف امل�صت�صفى اأطول 
مقارنة باملر�صى ذوي النتائج ال�صلبية )متو�صط 3 مقابل 1 يوم؛ P = 0.001(. باملجمل، فقط %28.2 من املر�صى ذوي النتائج املوجبة مت 
ت�صخي�صهم باأمرا�ض مرتبطة بالقلب مثل الف�صل القلبي، متالزمة ال�رشيان التاجي احلادة، الرجفان الأذيني واأنواع اأخرى من عدم النتظام. 
اخلال�صة: النتائج الإيجابية لفح�ض الرتوبونني جاءت مرتبطة بزيادة فرتة البقاء يف امل�صت�صفى، بالرغم من ذلك وجد اأن ن�صبة املر�صى 
الذين مت ت�صخي�صهم لحقا باأمرا�ض قلبية قليلة. القواعد الإر�صادية يجب اأن تو�صع للتاأكد من اأن فح�ض الرتوبونني يجرى يف احلالت 
املتوقعة ملتالزمة ال�رشيان التاجي احلادة فقط.
الكلمات املفتاحية: ق�صم الطوارئ؛ الرتوبونني؛ ت�صوه قلبي وعائي؛ متالزمة ال�رشيان التاجي احلادة؛ فرتة البقاء بامل�صت�صفى؛ عمان. 
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Advances in Knowledge 
- Emergency department patients should not undergo troponin testing unless an acute coronary syndrome is suspected. In this study, a 
high degree of inappropriate troponin testing was observed. 
Application to Patient Care
- The findings of this study highlight the need for protocols to guide troponin testing as, unless indicated, it can lead to unnecessary 
investigations and delayed patient discharge. Accordingly, a thoroughly clinical evaluation should be conducted prior to a test request.
Chest pain is one of the most common reasons for emergency department (ED) attendance.1 As there are many causes of chest 
pain, the emergency physician has the responsibility 
of ruling out potentially life-threatening and serious 
conditions, such as a myocardial infarction (MI), 
aortic dissection or pulmonary embolism. Necessary 
diagnostic investigations include a thorough patient 
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history and physical examination, chest X-rays, 12-
lead electrocardiography (ECG) and blood tests for 
myocardial injury biomarkers. Of these, the most 
widely used and extensively validated biomarkers for 
detecting cardiac cellular injury are cardiac troponins 
T and I (cTn-I) as they have a high sensitivity to and 
specificity for myocardial damage.2,3 
However, because the troponin test is very 
sensitive, an inevitable number of false-positive results 
is to be expected.4 As the main reason for testing 
cardiac troponin is to rule out an acute coronary 
syndrome (ACS), it is thus essential that troponin is 
only checked in circumstances where the probability 
of ischaemic heart disease is high and an ACS is 
suspected, especially as indiscriminate troponin 
testing can lead to unnecessary investigations or a 
misdiagnosis.5,6 This study therefore aimed to review 
patterns of troponin testing among patients attending 
the ED of the Sultan Qaboos University Hospital 
(SQUH) in Muscat, Oman, and to examine whether 
initial troponin test results had an effect on patient 
management, especially length of hospital stay (LOS).
Methods 
This retrospective study included all adult patients 
≥18 years old undergoing cTn-I testing following their 
admission to the ED of SQUH during July 2015. Patients 
who presented with a ST-elevation MI (STEMI) were 
excluded. The month of July was chosen at random 
for the study period. Patient data were obtained from 
the hospital’s electronic records. Troponin levels 
were considered positive at ≥0.04 μg/mL and 
negative at <0.04 μg/mL, as per the reference levels 
recommended by the manufacturer of the assay kit 
(AccuTnl+3 Reagent Kit, Beckman Coulter Inc., Brea, 
California, USA). The presenting complaints of the 
patients were classified as either cardiac or non-cardiac, 
with presenting cardiac complaints including chest 
pain, palpitations, breathlessness and epigastric pain. 
Epigastric pain was included as a cardiac symptom as 
it is potentially indicative of an atypical presentation of 
angina; furthermore, it is often difficult to distinguish 
between epigastric and retrosternal discomfort.7 The 
final diagnosis of each patient was categorised as 
either cardiac or non-cardiac, with cardiac diagnoses 
including heart failure, an ACS, atrial fibrillation or 
other forms of arrhythmia.
All statistical analyses were performed using 
the Statistical Package for the Social Science (SPSS), 
Version 21.0 (IBM Corp., Armonk, New York, USA). 
A P value of <0.050 was considered statistically 
significant. All categorical variables were presented 
as frequencies and percentages. Means and standard 
deviations were used to describe continuous normally 
distributed variables, while non-normally distributed 
variables were described as medians and interquartile 
ranges. A Chi-squared test was used to compare 
categorical variables between groups and a t-test was 
used to compare mean ages. A Mann-Whitney test 
was used to compare associations with LOS.
Ethical approval for this study was obtained from 
the Medical Ethics & Research Committee of the 
College of Medicine & Health Sciences, Sultan Qaboos 
University (MREC #1122).
Results
During the study period, a total of 4,845 patients 
attended the ED of SQUH. Of these, 599 adult patients 
underwent cTn-I testing as part of their evaluation; 
however, 11 patients with STEMIs were excluded 
from the analysis. Accordingly, a total of 588 patients 
underwent 681 troponin tests. The mean age of the 
participants was 56.6 ± 16.7 years and 53.9% were 
male. A total of 110 (18.7%) and 478 (81.3%) patients 
had positive and negative initial troponin results, 
Table 1: Demographic and clinical characteristics of 
emergency department patients undergoing troponin 
testing at the Sultan Qaboos University Hospital, 
Muscat, Oman (N = 588)











Male 66 (60.0) 251 (52.5)  
0.094
Female 44 (40.0) 227 (47.5) 
Age
Mean ± SD 61.6 ± 15.9 55.5 ± 16.8 0.001†
Comorbidities‡
Stroke 8 (7.3) 12 (2.5) 0.020
CABG 6 (5.5) 27 (5.6) 0.574
PCI 11 (10.0) 30 (6.3) 0.123
Renal failure 8 (7.3) 9 (1.9) 0.007
MI 9 (8.2) 11 (2.3) 0.006
HTN 56 (50.9) 215 (45.0) 0.158
Diabetes 40 (36.4) 170 (35.6) 0.484
SD = standard deviation; CABG = coronary artery bypass grafting; 
PCI = percutaneous coronary intervention; MI = myocardial 
infarction; HTN = hypertension.
*Calculated using a Chi-squared test. †Calculated using a Student’s 
t-test. ‡Percentages do not add up to 100% as patients may have 
had more than one comorbidity.
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respectively. Patients with positive troponin results 
were significantly older and more likely to have renal 
failure and MIs as comorbidities (P <0.050 each). 
However, there was no association between elevated 
troponin results and coronary artery bypass grafting, 
percutaneous coronary interventions, hypertension 
or diabetes (P >0.050) [Table 1]. 
A total of 342 patients (58.1%) presented with 
cardiac symptoms. Of these, chest pain was the most 
frequent (n = 135; 39.5%), followed by breathlessness 
(n = 118; 34.5%), epigastric pain (n = 74; 21.6%) and 
palpitations (n = 15; 4.4%). Interestingly, a large 
proportion of the patients (n = 246; 41.8%) did not 
present with any cardiac symptoms. Overall, only 65 
(19.0%) of those with cardiac symptoms had initial 
positive troponin test results, including 6.8% with 
epigastric pain. In addition, 18.3% of patients with 
non-cardiac symptoms also had raised troponin levels 
[Table 2].
In terms of management, 494 patients (84.0%) 
did not have a repeat troponin test and 93 (15.8%) 
underwent at least one repeat troponin test. Of those 
with initial positive troponin findings, 39 (35.5%) 
underwent multiple repeat troponin tests as compared 
to 54 (11.3%) with initial negative results. Only 33 
(30.0%) and 10 (9.1%) patients with positive troponin 
results were referred to a cardiologist or underwent 
ACS management, respectively. All 10 of these ACS 
patients received an angiogram, of which four were 
normal. Of those with initial negative troponin results, 
31 (6.5%) were referred to a cardiologist, seven (1.5%) 
underwent ACS management and four (0.8%) had an 
angiogram, of which two were normal. Patients with 
Table 2: Presenting complaints among emergency 
department patients undergoing troponin testing at 
the Sultan Qaboos University Hospital, Muscat, Oman 
(N = 588)










Chest pain 20 (14.8) 115 (85.2) 0.001
Breathlessness 35 (29.7) 83 (70.3) 0.001
Palpitations 5 (33.3) 10 (66.7) 0.001
Epigastric pain 5 (6.8) 69 (93.2) 0.001
Non-cardiac 
complaints
45 (18.3) 201 (81.7) 0.001
Table 3: Management and length of stay of emergency 
department patients undergoing troponin testing at the 
Sultan Qaboos University Hospital, Muscat, Oman 
(N = 588)










Treated as ACS 10 (9.1) 7 (1.5) <0.001
Angiography 10 (9.1) 4 (0.8) <0.001
Referred to a 
cardiologist
33 (30.0) 31 (6.5) <0.001
Initial troponin 
test only
71 (64.5) 424 (88.7) <0.001
At least one 
repeat troponin 
test
39 (35.5) 54 (11.3)
Median LOS in 
days (IQR)
3 (1–8) 1 (1–2) 0.001
ACS = acute coronary syndrome; LOS = length of hospital stay; IQR = 
interquartile range.
Table 4: Final diagnoses of emergency department 
patients undergoing troponin testing at the Sultan 
Qaboos University Hospital, Muscat, Oman (N = 588)









Cardiac† 31 (28.2) 66 (13.8)  
<0.001
Non-cardiac 79 (71.8) 412 (86.2)
*Calculated using a Chi-squared test.
†Including heart failure, an acute coronary syndrome, atrial fibrillation 
or other forms of arrhythmia.
Table 5: Correlations between presenting complaints 
and final diagnoses among emergency department 
patients undergoing troponin testing at the Sultan 
Qaboos University Hospital, Muscat, Oman (N = 588)
Presenting 
complaint








Chest pain 35 (36.1) 100 (20.4) <0.001
Breathlessness 27 (27.8) 91 (18.5) <0.001
Palpitations 5 (5.2) 10 (2.0) <0.001
Epigastric pain 9 (9.3) 65 (13.2) <0.001
Non-cardiac 
symptoms
21 (21.6) 225 (45.8) <0.001
*Including heart failure, an acute coronary syndrome, atrial fibrillation 
or other forms of arrhythmia.
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positive troponin test results had a significantly greater 
LOS compared to those with negative troponin find-
ings (mean: one versus three days; P <0.050) [Table 3].
A total of 97 patients (16.5%) had a final diagnosis 
related to a cardiac condition, consisting of 31 
patients (32.0%) with positive troponin tests and 66 
(13.8%) with negative results [Table 4]. Specifically, 
six patients (5.5%) with positive troponin test results 
and two (0.4%) with negative findings were diagnosed 
with ACS. Overall, 76 (22.2%) of patients with cardiac 
symptoms had a final cardiac diagnosis, including nine 
patients with epigastric pain [Table 5]. While a small 
proportion (n = 21; 8.5%) of those patients presenting 
with non-cardiac complaints also had a cardiac diag-
nosis, most of these cases did not have an ACS.
Discussion
To the best of the authors’ knowledge, this study 
is the first of its kind in the region to study the 
pattern of troponin testing in the ED of a large 
tertiary care centre. While the results indicated that 
cardiac troponin testing was performed mainly for 
patients with chest pain or in cases where an ACS 
was suspected, it was also occasionally requested 
for patients with non-cardiac-related symptoms. It 
is possible that the attending doctor in these cases 
requested troponin testing because they felt that the 
patient’s presentation might be the result of an atypical 
manifestation of an ACS. Moreover, not all of the 
patients with positive troponin results in the current 
study were treated for an ACS, while a small number 
of patients with negative troponin results underwent 
ACS management based on their clinical presentation. 
This finding is in keeping with the guidelines of the 
European Society of Cardiology which specify that 
while troponin testing has a role in diagnosing a MI, 
a negative test does not always rule out other forms of 
ACS, such as unstable angina.8 
Although troponin tests are widely available, 
not all hospitals have clear guidelines or protocols as 
to when a troponin test should be requested, which 
can inadvertently lead to the inappropriate use of 
this diagnostic investigation.5,6,9 While troponin tests 
are mainly used to diagnose an ACS, troponin levels 
can also be elevated in other cardiac conditions such 
as heart failure, tachyarrhythmias and post-cardiac 
arrest and direct current cardioversion as well as non-
cardiac conditions such as cerebrovascular accidents, 
head injuries, sepsis and pulmonary emboli.2–4 In these 
circumstances, a troponin test should only be 
performed if there is strong suspicion of an ACS—such 
as prior chest pain or ECG changes—as a positive result 
can be misleading.5,6 Interestingly, although 97 patients 
in the current study had a final cardiac-related diagnosis, 
only eight of these patients (8.2%) were diagnosed with 
an ACS. This number is relatively low and might reflect 
the short study period. In addition, there may have been 
a high incidence of type 2 MIs (i.e. infarctions due to 
demand-supply mismatch rather than plaque rupture), 
which are often overlooked.10,11 Unfortunately, patients 
with STEMIs were not included in the current analysis 
and it was beyond the scope of this study to examine 
the incidence of type 2 MIs.
As expected, patients with positive troponin test 
results in the present study had a significantly longer 
LOS than those with negative findings. These patients 
were also significantly more likely to be treated for ACS, 
be referred to a cardiologist and undergo angiography. 
However, only 30.0% of patients with positive troponin 
results were referred to cardiologists; it is likely that 
the remaining 70.0% of patients were not considered 
to have a significant cardiac condition and were 
therefore not referred. In these cases, it is unclear why 
the troponin test was requested if such patients were 
not subsequently referred to a cardiologist despite 
their raised troponin levels. This finding may perhaps 
reflect the routine ordering of blood tests rather 
than requests made based on the patient’s clinical 
presentation. Rehmani et al. similarly showed that 
62.2% of blood tests requested from an ED at a large 
tertiary centre were considered inappropriate and that 
only 3.8% influenced patient management.12 Along 
the same lines, only 6.5% of patients with negative 
troponin findings in the current study were referred 
to a cardiologist although 13.8% had a final cardiac-
related diagnosis. This apparent discrepancy could be 
due to the fact that cardiac diagnoses included atrial 
fibrillation, arrhythmias and heart failure. As such, 
some patients may have presented to the ED with non-
cardiac symptoms but nevertheless received a cardiac 
diagnosis; for example, patients with coexisting atrial 
fibrillation may have received a cardiac diagnosis 
despite this not being the main reason for their 
attendance at the ED. A final diagnosis of an ACS was 
only made in a very small percentage of patients. 
If an ACS is suspected and the initial troponin 
test result is negative, it is recommended that a repeat 
test be performed within six hours to completely rule 
out MIs and improve diagnostic accuracy.3,13 However, 
in the current sample, only a small number of patients 
underwent a second test and this proportion was even 
lower among those with an initial negative result. 
Research from other centres also indicates that these 
recommendations are not being followed.14,15 On the 
whole, the results of the current study confirmed 
those of similar studies conducted in other parts of the 
world.16,17 Such findings highlight the need for proper 
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ED guidelines and protocols for troponin test requests. 
Triage nurses or physicians often request a wide array 
of blood tests while the patient is waiting to be seen by 
a doctor.18,19 Although these measures may help reduce 
patient wait times, it often results in unnecessary tests 
being ordered.11,20,21 For economic reasons, it is prudent 
to limit such requests for unnecessary tests, in turn 
reducing unnecessary hospital stays and admissions.6 
This study was subject to certain limitations 
due to its retrospective nature and the method of 
data collection using patient records. The cTn-I tests 
were requested by various ED doctors or triage nurses 
without standard protocols to guide requests for 
troponin testing or to screen for an ACS or myocardial 
injuries or infarctions. In addition, patients with 
negative cTn-I results were not followed up during 
their subsequent stay in the ED or hospital. The final 
diagnosis of a cardiac or non-cardiac abnormality 
was based solely on documentation from the initial 
ED visit. Similarly, final cardiac diagnoses were not 
subcategorised according to the specific condition as 
this was beyond the scope of this study; the focus of 
the analysis lay in determining the pattern of cTn-I 
test requests and not in studying the prevalence of 
individual cardiac conditions. Moreover, the sample 
size of the study was small due to the short study 
period. Finally, a major limitation of this study was the 
unavailability of ECG data for most patients. 
Conclusion
In the current study, a large number of patients 
attending the ED were found to have undergone 
troponin testing despite presenting without cardiac-
related symptoms. Moreover, only a small proportion 
of patients with initial positive troponin test results 
received a final cardiac-related diagnosis upon 
discharge. Such unnecessary testing may lead to 
increased LOS and unnecessary referrals to the 
cardiology department. Hospital protocols regarding 
the appropriate use of troponin testing are therefore 
needed to guide emergency physicians and triage 
nurses.
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